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Abstract
Background: Widespread dissemination and implementation of evidence-based human immunodeficiency virus
(HIV) linkage-to-care (LTC) interventions is essential for improving HIV-positive patients’ health outcomes and
reducing transmission to uninfected others. To date, however, little work has focused on identifying factors
associated with intentions to adopt LTC interventions among policy makers, including city, state, and territory
health department AIDS directors who play a critical role in deciding whether an intervention is endorsed,
distributed, and/or funded throughout their region.
Methods: Between December 2010 and February 2011, we administered an online questionnaire with state,
territory, and city health department AIDS directors throughout the United States to identify factors associated with
intentions to adopt an LTC intervention. Guided by pertinent theoretical frameworks, including the Diffusion of
Innovations and the “push-pull” capacity model, we assessed participants’ attitudes towards the intervention,
perceived organizational and contextual demand and support for the intervention, likelihood of adoption given
endorsement from stakeholder groups (e.g., academic researchers, federal agencies, activist organizations), and
likelihood of enabling future dissemination efforts by recommending the intervention to other health departments
and community-based organizations.
Results: Forty-four participants (67% of the eligible sample) completed the online questionnaire. Approximately
one-third (34.9%) reported that they intended to adopt the LTC intervention for use in their city, state, or territory
in the future. Consistent with prior, related work, these participants were classified as LTC intervention “adopters”
and were compared to “nonadopters” for data analysis. Overall, adopters reported more positive attitudes and
greater perceived demand and support for the intervention than did nonadopters. Further, participants varied with
their intention to adopt the LTC intervention in the future depending on endorsement from different key
stakeholder groups. Most participants indicated that they would support the dissemination of the intervention by
recommending it to other health departments and community-based organizations.
Conclusions: Findings from this exploratory study provide initial insight into factors associated with public health
policy makers’ intentions to adopt an LTC intervention. Implications for future research in this area, as well as
potential policy-related strategies for enhancing the adoption of LTC interventions, are discussed.
Keywords: HIV/AIDS, Policy, Adoption, Linkage-to-care, Intervention
Correspondence: wenorton@uab.edu
Department of Health Behavior, School of Public Health, University of
Alabama at Birmingham, Birmingham, AL, USA
Norton Implementation Science 2012, 7:27
http://www.implementationscience.com/content/7/1/27
Implementation
Science
© 2012 Norton; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Introduction
Timely linkage of newly diagnosed human immunodefi-
ciency virus (HIV)-positive individuals to healthcare is
critical for improving patient health outcomes and redu-
cing transmission of HIV to uninfected others [1-4].
Unfortunately, approximately 20% to 40% of newly diag-
nosed HIV-positive patients in the United States fail to
be linked to care in a timely fashion [2,4-6]. Researchers
have identified numerous individual-, contextual-, and
structural-level factors associated with delayed entry to
HIV care [4,7-20]; importantly, such information has
served as the foundation for the development of several
linkage-to-care (LTC) interventions [21-27].
Despite the potential to improve patient and public
health outcomes [1-4,28,29], existing evidence-based
HIV LTC interventions have yet to be widely and sys-
tematically disseminated and implemented in commu-
nity-based organizations (CBOs) and health departments
throughout the United States. In order to accelerate
national-level scale-up, it is important to identify and
understand factors associated with intentions to adopt
LTC interventions and use this information to develop
and test strategies to encourage intervention adoption
and effective implementation among key end users,
including consumers, organizations, and policy makers.
While limited empirical evidence exists regarding bar-
riers to adoption and effective implementation of LTC
interventions (see [30] for a notable exception), related
work with evidence-based HIV prevention interventions
has identified a range of influential factors, including
characteristics of the intervention, organizational culture
and climate, program champions, financial resources,
and staffing [31-45]. For example, Miller [46] found
organizational commitment, resources, and maturity to
be distinguishing factors associated with the degree to
which an HIV prevention program was adopted in 38
CBOs. Additionally, DiFranceisco and colleagues [31]
identified individual- and organizational-level factors
associated with attitudes towards using research-based
HIV prevention interventions among a sample of 77
AIDS service organizations in the United States.
Comparatively less empirical work, however, has
focused on understanding factors associated with inten-
tions to adopt HIV interventions among city, state, and
territory policy makers (so-called small p policy makers
[47,48]), including state, city, and territory health
department AIDS directors. Indeed, health department
AIDS directors play a critical role in the dissemination
and implementation of interventions in their state, city,
or territory, as they are able to actively promote and
endorse the adoption of particular interventions within
their coverage area or allocate funds for the implemen-
tation of particular interventions. Indeed, little is known
about factors that influence policy makers’ decision-
making process regarding the adoption of evidence-
based HIV-focused interventions, including LTC
interventions.
Given the paucity of research on factors affecting
health department AIDS directors’ intentions to adopt
evidence-based HIV-focused interventions, combined
with their “gatekeeper” status and potential role in
accelerating dissemination efforts, the objectives of the
present study were two-fold: (1) to characterize health
department AIDS directors’ overall intentions to adopt
an evidence-based LTC intervention for use in their
state, city, or territory and (2) to compare responses
between participants classified as “adopters” versus
“nonadopters” on key theory-based constructs.
The current study focused on the adoption of a speci-
fic evidence-based LTC intervention, ARTAS (i.e., Anti-
retroviral Treatment Access Study) [19,22,23]. Briefly,
ARTAS is a multisession, strengths-based case manage-
ment [49,50] intervention designed to link newly diag-
nosed HIV-positive individuals to HIV medical care. In
the ARTAS intervention, newly diagnosed HIV-positive
individuals meet with a case manager up to five times
o v e ra9 0 - d a yp e r i o d .D u r i n gt h e s es e s s i o n s ,t h ec a s e
manager builds rapport with the client, helps the client
identify barriers toward accessing HIV medical care, dis-
cusses strategies for overcoming these barriers, and sup-
ports the client in seeking HIV medical care. We opted
to focus specifically on ARTAS because it is the only
LTC intervention to date that has demonstrated positive
outcomes in both an efficacy and an effectiveness trial
[19,22,23], thus providing strong evidence to warrant its
widespread use.
Methods
Participants
Eligible participants included the 65 health department
AIDS directors from all 50 US states, US territories (n = 8;
American Samoa, Guam, Marshall Islands, Micronesia,
Northern Mariana Islands, Palau, Puerto Rico, and Virgin
Islands), the District of Columbia, and six major US cities
that receive direct funding from the Centers for Disease
Control and Prevention (CDC; i.e., Chicago, Houston, Los
Angeles, New York, Philadelphia, and San Francisco). The
study was approved by the Institutional Review Board at
the University of Alabama at Birmingham.
Procedure
Contact information for each of the 65 AIDS directors
was obtained from the online directory of the National
Alliance of State and Territorial AIDS Directors (NAS-
TAD; http://www.nastad.org), a nonprofit national asso-
ciation of state and territory health department HIV/
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department websites, as needed. Individuals were invited
to participate in the study via email, which included a
link to a 30-minute questionnaire administered through
Survey Monkey (http://www.surveymonkey.com, 2011).
Data collection occurred from December 2010 to Febru-
ary 2011. The questionnaire included survey items, as
well as a brief description of ARTAS (e.g., content, pur-
pose, prior research evidence, and recommended staff-
ing) in order to facilitate informed decision making. If
directors felt that they were not the most appropriate
person to complete the questionnaire, they were asked
to forward the study invitation to an appropriate repre-
sentative within the health department (e.g., AIDS pre-
vention coordinator/program manager). Participants
received email and/or phone reminders each week for
up to three weeks after initial contact and were provided
the option of receiving a $30 Visa gift card for participa-
tion in the study.
Measures
In absence of a standardized questionnaire designed spe-
cifically for our target population (e.g., health depart-
ment AIDS directors) and evidence-based intervention
(e.g., LTC intervention), we drew on several theoretical
frameworks to inform the selection of key constructs in
our questionnaire [47,51,52]. Guided by Rogers’ Diffu-
sion of Innovations Theory [52], we included measures
to assess participants’ attitudes towards the intervention,
since attributes of the innovation are associated with
innovation adoption [53]. The Diffusion of Innovations
Theory also informed our selection of measures to
assess participants’ likelihood of adoption given endorse-
ment from key stakeholder groups, which served as a
proxy for assessing communication channels [52]
through which an innovation may be received or pro-
mulgated, again influencing end-user adoption. Consis-
tent with Orleans’ push-pull capacity model [51,54], we
also included constructs to assess health department
AIDS directors’ perceived demand and support for the
LTC intervention, as “pull” factors can hinder or facili-
tate the adoption of innovations. Validated measures
from prior studies [53,55-58] were adapted for the speci-
fic context of the present study and used to assess the
above-mentioned constructs. Finally, we solicited expert
review of the questionnaire from key representatives and
researchers from CDC, NASTAD, and academia in an
effort to bolster the reliability and validity of our find-
ings given the dearth of validated measures in evidence-
based public health policy research.
Demographic items
Demographic items included age, gender, race/ethnicity,
and educational attainment. Participants were asked to
identify their current job position (e.g., health depart-
ment director, health department prevention coordina-
tor, other), years in current position, and years worked
for the health department. Categorical or continuous
response options were provided, as appropriate. These
items were selected based on use in a prior study exam-
ining the dissemination of physical activity programs
among state health departments in the United States
[55].
Intention to adopt ARTAS
Directors’ intentions to adopt ARTAS for use in their
city, state, or territory was assessed by a single item, “I
will adopt ARTAS for use in my city, state, or territory,”
and measured on a five-point Likert scale (1 = strongly
disagree, 5 = strongly agree).
Attitudes towards ARTAS
Directors’ attitudes towards ARTAS were assessed on a
17-item scale. Consistent with the Diffusion of Innova-
tions Theory [52], we assessed participants’ attitudes
towards attributes of ARTAS, including its relative
advantage (i.e., degree to which an innovation is per-
ceived as better than the idea it supersedes [52]), com-
plexity (i.e., degree to which an innovation is perceived
as difficult to understand or use [52]), compatibility (i.e.,
degree to which an innovation is perceived as being
consistent with the existing values, past experiences, and
needs of potential adopters [52]), observability (i.e.,
degree to which the results of an innovation are visible
to others [52]), and trialability (i.e., degree to which an
innovation may be experimented with on a limited basis
[52]). We also assessed participants’ attitudes towards
intervention effectiveness (i.e., performance [59]), cost (i.
e., money or other resources [59]), and simplicity (i.e.,
inverse of complexity [59]) based on our review of the
literature [53,56,58,59]. Sample items include, “Even
though ARTAS was shown to be effective in research
trials, it wouldn’t really work in my city, state, or terri-
tory,”“ ARTAS would have a visible and substantial
impact on the health status of newly diagnosed HIV-
positive individuals in my city, state, or territory,” and
“ARTAS is too complex” (reverse scored). Items were
assessed on a five-point Likert scale (1 = strongly dis-
agree, 5 = strongly agree). Due to high inter-item corre-
lation, we created a summed scale of attitudes towards
ARTAS, with higher scores indicating more positive atti-
tudes towards ARTAS. The scale demonstrated good
reliability (a = 0.85).
Perceived demand and support for ARTAS
Directors’ perceptions of demand and support for
ARTAS were assessed on a nine-item scale. Consistent
with the push-pull capacity model [51], we included
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potential end-user organizations (e.g., CBOs, local health
departments), members of the target population (e.g.,
HIV-positive individuals), and the director’s own health
department. Sample items include, “There would be a
high demand for ARTAS by community-based organiza-
tions in my city, state, or territory” and “Linking newly
diagnosed HIV-positive individuals to medical care is a
high priority in my health department.” Items assessed
perceived support for ARTAS among political leaders (e.
g., governor/mayor and legislature/city council) and
health department staff (e.g., administrators and man-
agers). Sample items include, “The governor of my state
or territory/mayor of my city would NOT support the
use of ARTAS” and “The state and territory legislature/
city council would NOT support the use of ARTAS”
(reverse scored). All items were assessed on a five-point
Likert scale (1 = strongly disagree, 5 = strongly agree).
We created a summed scale of perceived demand and
s u p p o r tf o rA R T A S ,w i t hh i g h e rs c o r e si n d i c a t i n g
greater perceived demand and support. The scale
demonstrated relatively poor reliability (a = 0.51).
Likelihood of adoption given endorsement from
stakeholders
Fourteen items were used to assess directors’ likelihood
of adopting ARTAS based on recommendations and
endorsement from a variety of key stakeholder groups,
as a proxy for assessing communication channels [52].
We selected a range of professional, peer, and nationally
based stakeholder organizations involved in HIV care
and treatment that would be potential marketing chan-
nels for the dissemination of ARTAS in the future.
These key stakeholder groups included (1) other states,
cities, or territories in the same region; (2) other health
department AIDS directors; (3) academic researchers;
(4) CBOs; (5) health departments; (6) professional orga-
nizations (e.g., HIV Medicine Association); (7) councils/
groups (e.g., National Minority AIDS Council); (8) NAS-
TAD; (9) activist organizations (e.g., Community HIV/
AIDS Mobilization Project); (10) reputable, online web-
sites (e.g., http://www.thebody.com); (11) US govern-
ment’s National AIDS Strategy; (12) Health Resources
and Services Administration (HRSA); (13) Veterans
Administration (VA); and (14) CDC. Each item asked,
“If ARTAS was recommended and endorsed by (name
of stakeholder group), I would adopt it for use in my
state, city, or territory.” Responses were assessed indivi-
dually on a five-point Likert scale (1 = strongly disagree,
5 = strongly agree).
Enabling intervention dissemination
Three items were used to assess whether or not direc-
tors intended to enable future dissemination efforts by
recommending ARTAS to other key stakeholders,
including (1) other health department AIDS directors;
(2) CBOs within their city, state, or territory; and (3)
local health departments within their state or territory
(as applicable). Each item stated, “Iw o u l dr e c o m m e n d
ARTAS to (name of key stakeholder group).” Each item
was assessed individually by stakeholder group on a
five-point Likert scale (1 = strongly disagree, 5 =
strongly agree).
Data analysis
Consistent with the first objective of our exploratory
study, descriptive statistics were used to characterize
the overall sample in terms of demographics. Descrip-
tive statistics were also used to characterize responses
to individual items assessing directors’ attitudes
towards ARTAS, perceived demand and support for
ARTAS, likelihood of adopting ARTAS given endorse-
ment and recommendation from others, and likelihood
of enabling intervention dissemination. Inter-item cor-
relations and scale reliability were examined within
measures; average scores were computed for scales,
where appropriate. Consistent with the second objec-
tive of our exploratory study, we compared responses
between adopters versus nonadopters on key con-
structs. Following the approach used in prior research
[55], participants were classified as adopters if they
responded agree or strongly agree to the single item
assessing adoption intentions; those who indicated any
other response option (i.e. ,n e i t h e ra g r e en o rd i s a g r e e ,
disagree, and strongly disagree) were classified as non-
adopters. One-way independent samples t-tests were
conducted to examine differences between adopters
and nonadopters on demographic variables and average
scores (where applicable). All analyses were conducted
in SPSS v. 17 (SPSS, Inc., Chicago, IL, USA).
Results
Participant characteristics
Table 1 summarizes demographic characteristics of the
overall sample. Of 65 eligible participants, 47 agreed to
participate (72%), and 42 provided complete responses
to all items (64%). Of the five individuals who provided
incomplete responses, two initiated the survey but indi-
cated that they were already implementing an LTC
intervention, and thus declined to answer any questions
because they did not think it was applicable. Two other
participants completed the majority of the questionnaire
but failed to answer the last few questions. One indivi-
dual provided his/her name, but did not answer any of
the survey items. Thus, analyses for the present study
were restricted to 44 individuals who provided responses
to the majority of the questionnaire, representing
approximately 67% of the total eligible sample.
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(n = 24, 54.5%), and between 46 and 55 years old (n =
18, 40.9%). Many participants reported having at least a
bachelor’s degree (n = 20); several also reported having
a Master’s degree (n = 26). The majority of participants
self-identified as the health department AIDS director (n
= 29, 67.4%), while a few participants identified as the
department AIDS prevention coordinator/program man-
ager (n = 9, 20.9%) or other (e.g., director of policy,
director of evaluation, or LTC coordinator; n = 5,
11.7%). Most participants had been in their current
position for less than five years (n = 26, 59.1%).
Intentions to adopt ARTAS
Among the 43 participants who provided a response to
the item that assessed intentions to adopt ARTAS, 15
(34.9%) responded agree or strongly agree and were sub-
sequently classified as adopters. Consistent with prior
work [55], the remaining 28 participants (65.1%) who
responded strongly disagree, disagree, or neither agree
nor disagree were classified as nonadopters for between-
group analyses.
Attitudes towards ARTAS
Descriptive statistics and differences between adopters
and nonadopters on each individual item assessing atti-
tudes towards ARTAS can be found in Additional file 1:
Appendix A. On average, participants classified as adop-
ters reported more positive attitudes towards ARTAS
(M = 3.62, standard deviation [SD] = 0.40) than those
classified as nonadopters (M = 3.21, SD = 0.32), t(41) =
3.65, p = .001.
Perceived demand and support for ARTAS
Descriptive statistics and differences between adopters
and nonadopters on each individual item assessing per-
ceived demand and support for ARTAS can be found in
Additional file 1: Appendix B. On average, participants
classified as adopters reported greater perceived demand
and support for ARTAS (M = 3.91, SD = 0.40) than
those classified as nonadopters (M = 3.66, SD = 0.29), t
(41) = 2.38, p = .02. These findings should be inter-
preted with caution, however, given poor scale reliability
(a = .51).
Likelihood of adoption given endorsement from
stakeholders
Overall, as displayed in Table 2 a greater percentage of
participants reported intentions to adopt ARTAS in the
future if ARTAS was recommended and endorsed by
CDC (59.1%), the US National HIV/AIDS Strategy
(59.1%), HRSA (56.8%), NASTAD (54.5%), or a state,
city, or territory health department AIDS director whom
the participant respected and trusted (50%). Conversely,
a lower percentage of participants reported intentions to
adopt ARTAS in the future if ARTAS was recom-
mended and endorsed by reputable online websites
(18.2%), VA (25%), or activist organizations (25.6%).
Enabling intervention dissemination
Most participants reported that they would recommend
ARTAS to other health departments (56.8%); CBOs in
their city, state, or territory (54.5%); and local health
departments in their state or territory (61%),
respectively.
Discussion
In the current sample of city, state, and territory health
department AIDS directors in the United States, 34.9%
reported that they would adopt ARTAS for use in their
Table 1 Demographic characteristics of participants (N =
44)
Variable N (%)
Gender 18 (40.9%)
Male 24 (54.5%)
Female
Race/ethnicity 31 (75.6%)
White 10 (24.3%)
Nonwhite
a
Age (years) 3 (6.8%)
25-35 11 (25.0%)
36-45 18 (40.9%)
46-55 10 (22.7%)
56-65
Educational degree(s) 6
High school diploma/GED 20
BA/BS 26
MA/MS 7
MD/PhD (or equivalent) 6
Other
Current position 29 (67.4%)
AIDS Director 9 (20.9%)
AIDS Prevention Program Coordinator 5 (11.6%)
5 (11.6%)
Years in current position 26 (59.1%)
Less than 5 7 (15.9%)
5-10 7 (15.9%)
11-15 2 (4.7%)
16 or more
Years in health department 13 (29.5%)
Less than 5 9 (20.5%)
5-10 9 (20.5%)
11-15 (29.5%)
16 or more
aCollapsed due to small cell sizes; includes Native American (n = 1), Pacific
Islander (n = 4), Hispanic/Latino (n = 2), and African American (n = 3).
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[55,60] and several theoretical frameworks [51,52], parti-
cipants classified as adopters indicated more positive
attitudes towards the LTC intervention and greater per-
ceived demand for ARTAS than those classified as non-
adopters. Intentions to adopt ARTAS varied by the type
of stakeholder group recommending and endorsing the
intervention; greater likelihood of adoption was observed
when the LTC intervention was hypothetically endorsed
by the National HIV/AIDS Strategy and CDC than if
endorsed by reputable online websites and VA. Finally,
most participants reported that they would recommend
ARTAS to other health departments, CBOs, and local
health departments (where applicable).
Findings from this exploratory questionnaire study
provide an initial description and identification of the-
ory-based constructs associated with intentions to adopt
an evidence-based LTC intervention among city, state,
and territory health department AIDS directors through-
out the United States. Importantly, future research may
focus on developing strategies to increase positive atti-
tudes toward the intervention, create demand and sup-
port for the intervention, and leverage particular
stakeholder groups as effective intervention marketing
channels in order to encourage and accelerate the adop-
tion of LTC interventions among city, state, and terri-
tory health department AIDS directors.
While the current study provides an initial step
towards better understanding policy makers’ decision-
making processes regarding the adoption of LTC
interventions, additional work is needed to develop this
area of inquiry further. Indeed, although evidence-based
public health policy research has gained momentum in
the past decade, especially in the areas of tobacco, can-
cer, physical activity, and school health [47,61,62], the
field would benefit from programmatic efforts to
advance both theory and measurement across a variety
of public health areas. In the interim, the existing body
of work can serve as a starting point for the develop-
ment of more robust evidence-based public health pol-
icy research with specific application towards HIV
prevention, treatment, and care interventions.
Several limitations of the current study should be
noted. First, responses may be subject to social desirabil-
ity bias. While procedural safeguards were implemented
to reduce such bias (e.g., online questionnaire completed
at the discretion of the participant’s availability and loca-
tion), it is possible that participants may have provided
less-than-accurate responses because the survey was not
anonymous. However, having an independent group (e.
g., academic-affiliated investigator) administer the online
survey–rather than an entity charged with allocating
funds (e.g., CDC, HRSA)–may have reduced the likeli-
hood of biased responses. Second, as is common across
most areas of dissemination and implementation
research [63], and particularly within evidence-based
public health policy research [47,63], the present study
lacked established measures for assessing city, state, and
territory policy makers’–specifically health department
AIDS directors’–intentions to adopt ARTAS in the
Table 2 Descriptive characteristics of intention to adopt ARTAS given endorsement from various stakeholder groups
(N = 44)
Item M SD Agree or strongly agree
(%)
If ARTAS was recommended and endorsed by [stakeholder group], I would adopt it for use in my state, city,
or territory.
Stakeholder groups:
... other departments in my geographic region 3.34 0.56 34.1%
... a state, city, or territory AIDS director who I respected and trusted 3.56 0.69 50.0%
... academic researchers 3.45 0.66 40.9%
... community-based organizations that have used it in the past 3.36 0.65 36.4%
... health departments that have used it in the past 3.50 0.62 47.7%
... professional organizations (e.g., HIV Medicine Association) 3.25 0.62 30.2%
... HIV/AIDS-related councils or groups (e.g., National Minority AIDS Council) 3.29 0.63 34.1%
... National Alliance of State and Territory AIDS Directors (NASTAD) 3.68 0.77 54.5%
... activist organizations (e.g., Community HIV/AIDS Mobilization Project) 3.23 0.64 25.6%
... reputable, online websites (e.g., www.thebody.com) 3.11 0.57 18.2%
... as part of the National AIDS Strategy 3.75 0.78 59.1%
... Health Resources and Services Administration (HRSA) 3.65 0.77 56.8%
... Veterans Administration (VA) 3.22 0.64 25.0%
... Centers for Disease Control and Prevention (CDC) 3.77 0.80 59.1%
Note: 1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = strongly agree.
ARTAS = Antiretroviral Treatment Access Study.
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informed by theoretical frameworks; measures used in
related-research studies [47,51,52,60,62,64]; and input
from expert representatives from CDC, NASTAD, and
academia, future work is needed to validate these mea-
sures with other HIV-focused interventions and to
determine their predictive utility in discriminating
between those who actually adopt versus do not adopt
interventions in the future.
Identifying ways to promote the adoption of evidence-
based LTC interventions among policy makers has the
potential to accelerate the transition of such interven-
tions from research to practice settings at the national
level, which is essential for realizing the population ben-
efits of our research investments. Although exploratory,
the present study contributes to the evidence base in
this area and seeks to instigate additional inquiry into
this field in a concerted effort to spread evidence-based
LTC interventions more quickly and effectively through-
out the United States.
Endnote
aFor some analyses, N = 43 because of incomplete data
or refusal to answer a question.
Additional material
Additional file 1: Appendix A. Descriptives and Differences between
Non-adopters (n = 28) and Adopters (n = 15) on Attitudes Towards
ARTAS. Appendix B. Descriptives and Differences between Non-adopters
(n = 28) and Adopters (n = 15) on Perceived Organizational and
Contextual Demand and Support.
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